ArticleLeukemia2006

Maintained immunogenicity of chronic myeloid leukemia-derived dendritic cells in the presence of imatinib mesylate: implication for vaccination regimens.

T M Westers et al.PubMed ↗Publisher ↗

No numbers read from the abstract.